Browsing: Therapeutics

[ad_1] Relay Therapeutics announces proposed public offering of common stock [ad_2] Source: Seekingalpha

[ad_1] Relay Therapeutics (NASDAQ:RLAY) on Monday mentioned it has commenced an underwritten public offering of $200 million of shares of its common stock. Relay Therapeutics additionally…

[ad_1] Seres Therapeutics jumps on report of Nestle acquisition offer [ad_2] Source: Seekingalpha

[ad_1] Ozgu Arslan/iStock by way of Getty Images Seres Therapeutics (NASDAQ:MCRB) rose 7% on a report that Nestlé (OTCPK:NSRGY) made an acquisition offer for the corporate…

[ad_1] Ozgu Arslan/iStock by way of Getty Images Seres Therapeutics (NASDAQ:MCRB) rose 7% on a report that Nestlé (OTCPK:NSRGY) made an acquisition offer for the corporate…

[ad_1] TransCode Therapeutics secures $2M grant for lead candidate [ad_2] Source: Seekingalpha

[ad_1] Qualigen Therapeutics stock falls after it prices $3.46M public offering [ad_2] Source: Seekingalpha

[ad_1] Biora Therapeutics granted extension to regain compliance with Nasdaq [ad_2] Source: Seekingalpha

[ad_1] Pfizer in collaboration with Quotient Therapeutics for CV, kidney disease therapies [ad_2] Source: Seekingalpha

[ad_1] narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency…